Canada markets close in 3 hours 53 minutes

Skye Bioscience, Inc. (SKYE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.000.00 (0.00%)
As of 12:01PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
5,588
5,819
6,012
2,931
1,944
Selling General and Administrative
5,902
7,852
6,095
4,916
4,345
Total Operating Expenses
11,490
13,672
12,106
7,848
6,289
Operating Income or Loss
-
-13,672
-12,106
-7,848
-6,289
Interest Expense
812.638
906.27
665.133
769.159
706.385
Total Other Income/Expenses Net
207.59
-23,163
-6,602
96.788
436.27
Income Before Tax
-12,097
-37,641
-19,475
-8,520
-6,559
Income Tax Expense
5.641
3.6
6.741
2.1
1.6
Income from Continuing Operations
-12,103
-37,645
-19,482
-8,522
-6,561
Net Income
-12,103
-37,645
-19,482
-8,522
-6,561
Net Income available to common shareholders
-12,103
-37,645
-19,482
-8,522
-6,561
Basic EPS
-11.55
-
-8.77
-5.00
-7.50
Diluted EPS
-11.55
-
-8.77
-5.00
-7.50
Basic Average Shares
4,639
-
2,221
1,626
922.987
Diluted Average Shares
4,639
-
2,221
1,626
925.683